Status:
COMPLETED
The Compassion and Attention Longitudinal Meditation Study
Lead Sponsor:
University of Arizona
Collaborating Sponsors:
Emory University
Conditions:
Immune System Processes
Inflammatory Activation and Modulation
Eligibility:
All Genders
25-55 years
Phase:
NA
Brief Summary
The increasingly widespread use of meditation for stress-related emotional and medical conditions highlights the urgent need to rigorously evaluate mechanisms through which the benefits of practice mi...
Eligibility Criteria
Inclusion
- Good medical health
Exclusion
- current major depression
- current substance abuse
- lifetime history of schizophrenia or bipolar disorder type I as assessed by the Structured Diagnostic Interview for DSM-IV (SCID)
- suicidal ideation or suicide attempt within one year of study enrollment
- diagnosis of any serious ongoing medical condition including malignancy, auto-immune disease (i.e. rheumatoid arthritis, multiple sclerosis, Crohn's disease), cardiovascular disease (other than hypertension), seizure disorder, endocrinopathy, chronic infection (i.e. human immunodeficiency virus, hepatitis B or C), renal or hepatic insufficiency, or any other current or past medical or psychiatric condition that might increase the risk of study participation in the opinion of study personnel
- treatment with psychotropic medications within the last year (i.e. antidepressants, anxiolytics, psychostimulants or mood stabilizers)
- active ongoing psychiatric treatment at the time of enrollment.
- use of any psychotropic medication (i.e. antidepressants, anxiolytics, psychostimulants or mood stabilizers) within one year of screening.
- chronic use of anti-inflammatory/immunosuppressive agents, including, but not limited to, aspirin, non-steroidal anti-inflammatory agents, COX-2 inhibitors, corticosteroids, etanercept, infliximab, adalimumab or methotrexate.
- any significant past meditation training/experience (defined as meditating more than 3 times a week for a period longer than a month)
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
226 Patients enrolled
Trial Details
Trial ID
NCT01251341
Start Date
September 1 2009
End Date
May 1 2014
Last Update
December 5 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University
Atlanta, Georgia, United States, 30322